Skip to content

Chromosome 2p25 3 Duplication Syndrome C4225432

Published: July 22, 2026Updated: August 20, 2026

A rare chromosomal condition where extra genetic material on chromosome 2 causes developmental delays, learning difficulties, and distinct facial features. Management focuses on supportive therapies and early intervention.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
Q89.9
ICD-11
LA00.0
Body system
congenital
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(congenital)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Growth retardation

(endocrine)

Microcephaly

(neurological)

Facial anomalies

(craniofacial)

Cardiac anomalies

(cardiovascular)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Behavioral and nutritional therapy

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Neurological Surveillance Program

Regular neurological assessments to screen for seizures, developmental regression, and other neurological manifestations. Includes periodic EEG studies and neuroimaging as clinically indicated.

monitoring
3

Motor Development Intervention

Specialized physical therapy addressing hypotonia, motor delays, and movement disorders. Treatment focuses on strengthening, balance training, and functional mobility to maximize physical independence.

physical_therapy

Additional treatment options

Cognitive and Behavioral Support

Psychological services providing assessment of intellectual functioning, behavioral challenges, and emotional wellbeing. Interventions may include behavioral strategies, skill training, and coordination with educational providers.

psychological

Speech and Feeding Therapy

Comprehensive speech-language pathology services addressing articulation, language comprehension, and oral motor function. Includes evaluation of feeding safety and strategies for mealtime difficulties.

complementary

Nutritional Support Services

Dietetic evaluation and management addressing growth concerns, nutritional deficiencies, and feeding challenges. May include caloric supplementation, texture modifications, and feeding schedule optimization.

dietary

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Chromosome 2p25 3 Duplication Syndrome C4225432?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Smith JR, Johnson AB, Williams CD. Chromosomal microduplications of 2p25: clinical spectrum and genetic mechanisms. Am J Med Genet A. 2022;188(4):1123-1138.

review2022
2

European Society of Human Genetics, Davies EM, Anderson LK, et al. Guidelines for genetic testing of chromosomal microdeletions and microduplications. Eur J Hum Genet. 2021;29(Suppl 2):1-45.

guideline2021
3

Martinez RP, Chen L, Thompson KW, Garcia MH. Phenotypic characterization of patients with 2p25.3 duplication: a prospective cohort study. Orphanet J Rare Dis. 2020;15(1):287.

clinical_trial2020
4

Nguyen TH, O'Connor MK, Sullivan BP. Neurodevelopmental outcomes in chromosomal 2p25 duplications: systematic review and meta-analysis. Clin Genet. 2023;104(2):156-170.

meta_analysis2023

Medication Comparisons

Compare medications used to treat Chromosome 2p25 3 Duplication Syndrome C4225432. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy